SNRP Program at UCC
UCC 的 SNRP 项目
基本信息
- 批准号:7119999
- 负责人:
- 金额:$ 152.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-09-30 至 2010-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): The SNRP-1 Program at UCC is centered around three research topics: norepinephrine modulation of sensitization to cocaine, neuroprotection by nicotine and tobacco cembranoids, and cembranoid mechanism of action on nicotinic receptors. A Natural Products Core provides tobacco and marine cembranoids, both known and new. Each project is performed in collaboration with a collaborator from a research-intensive institution: UCLA, Cornell U. (Ithaca) and the Vollum Institute (OHSU). SNRP-1 was funded since October 1999. Four RO1 proposals were presented to the NIH during the third year, three of which are now in the process of re-submission. Thirty nine manuscripts were published in peer-reviewed journals. Among the scientific discoveries reported, we would like to mention the following: 1) Noradrenergic transmission through alpha-2 receptors mediates some of the inhibitory effects of cocaine in the prefrontal cortex. 2) Both nicotine and tobacco cembranoids protect the hippocampal slice from NMDA-induced excitotoxicity, but the signal transduction pathways are different. 3) Cembranoids are nicotinic antagonists whose inhibitory action can be released by certain cocaine derivatives. We now propose to continue this successful program for a second cycle of five years. Three new scientists will address the issues of oxidative damage in Huntington disease, direct effects of thyroid hormones on the nAChR and on synapse remodelling, and modulation of potassium channels by spermine. Collaborators are from Washington University and UCLA. Program activities include seminars, courses, travel, etc. A transition plan from SNRP-1 to RO1 funding, is proposed for the present investigators. A plan to attract Puerto Rican Ph.Ds to postdoctoral positions with SNRP scientists at UCC is also presented.
描述(由申请人提供):UCC SNRP-1项目围绕三个研究主题:去甲肾上腺素对可卡因致敏的调节,尼古丁和烟草类膜膜的神经保护作用,以及类膜膜对尼古丁受体的作用机制。天然产品核心提供烟草和海洋类膜,已知的和新的。每个项目都与来自研究密集型机构的合作者合作完成:加州大学洛杉矶分校,康奈尔大学(伊萨卡)和Vollum研究所(OHSU)。SNRP-1从1999年10月开始得到资助。在第三年向NIH提交了四份RO1提案,其中三份目前正在重新提交过程中。39篇论文在同行评议期刊上发表。在报告的科学发现中,我们想提到以下几点:1)通过α -2受体的去甲肾上腺素能传递介导了可卡因在前额皮质的一些抑制作用。2)尼古丁和烟草类膜均能保护海马片免受nmda诱导的兴奋性毒性,但信号转导途径不同。3)类樟脑是尼古丁拮抗剂,其抑制作用可由某些可卡因衍生物释放。我们现在提议将这个成功的项目延续到第二个五年周期。三位新科学家将解决亨廷顿病的氧化损伤问题,甲状腺激素对nAChR和突触重塑的直接影响,以及精胺对钾通道的调节。合作者来自华盛顿大学和加州大学洛杉矶分校。项目活动包括研讨会、课程、旅游等。为目前的研究人员提出了从SNRP-1到RO1资助的过渡计划。还提出了一项吸引波多黎各博士到UCC与SNRP科学家一起担任博士后职位的计划。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
VESNA Ana ETEROVIC其他文献
VESNA Ana ETEROVIC的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('VESNA Ana ETEROVIC', 18)}}的其他基金
Neuroscience Research, Training and Professional Development in Puerto Rico
波多黎各的神经科学研究、培训和专业发展
- 批准号:
8711574 - 财政年份:2013
- 资助金额:
$ 152.12万 - 项目类别:
Neuroscience Research, Training and Professional Development in Puerto Rico
波多黎各的神经科学研究、培训和专业发展
- 批准号:
8901320 - 财政年份:2013
- 资助金额:
$ 152.12万 - 项目类别:
Pilot--Molecular features of cembranoids as nicotinic a
中试--烟碱类西松烷内酯的分子特征
- 批准号:
7312787 - 财政年份:2006
- 资助金额:
$ 152.12万 - 项目类别:
Pilot--Molecular features of cembranoids as nicotinic a
中试--烟碱类西松烷内酯的分子特征
- 批准号:
7120465 - 财政年份:2005
- 资助金额:
$ 152.12万 - 项目类别:
相似海外基金
Discovery of analgesic diterpenoid alkaloids from medicinal Aconitum plants using a metabolomic approach
使用代谢组学方法从药用乌头植物中发现镇痛二萜生物碱
- 批准号:
10629875 - 财政年份:2023
- 资助金额:
$ 152.12万 - 项目类别:
Elucidating and engineering eleutherobin biosynthesis
阐明和工程化刺五加酶生物合成
- 批准号:
10572627 - 财政年份:2023
- 资助金额:
$ 152.12万 - 项目类别:
Unified total synthesis of the unexplored densely oxygenated daphnane diterpenes for drug lead discovery
未开发的浓氧瑞香二萜的统一全合成用于药物先导物的发现
- 批准号:
22K06521 - 财政年份:2022
- 资助金额:
$ 152.12万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Chemical Synthesis of Bioactive Diterpenoids
生物活性二萜类化合物的化学合成
- 批准号:
10405930 - 财政年份:2022
- 资助金额:
$ 152.12万 - 项目类别:
Structural determination of new nitrogenous labdane-type diterpenes from ginger extract and elucidation of their biosynthetic mechanism
生姜提取物中新型含氮拉丹烷型二萜的结构测定及其生物合成机制的阐明
- 批准号:
22K05473 - 财政年份:2022
- 资助金额:
$ 152.12万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Improved carnosic acid congener compounds for Alzheimer’s disease
改进的鼠尾草酸同系物化合物可治疗阿尔茨海默病
- 批准号:
10601159 - 财政年份:2022
- 资助金额:
$ 152.12万 - 项目类别:
Refactoring Soft Coral Diterpenoid Biosynthesis
重构软珊瑚二萜生物合成
- 批准号:
10553605 - 财政年份:2022
- 资助金额:
$ 152.12万 - 项目类别:
Refactoring Soft Coral Diterpenoid Biosynthesis
重构软珊瑚二萜生物合成
- 批准号:
10389172 - 财政年份:2022
- 资助金额:
$ 152.12万 - 项目类别:
A Concise, Enantioselective Approach to the Synthesis of (-)-Rhodomollanol-A
(-)-红多酚-A 的简洁、对映选择性合成方法
- 批准号:
10627806 - 财政年份:2021
- 资助金额:
$ 152.12万 - 项目类别:
Understanding Oligomer Assembly of Isoprenoid and Terpene Synthases
了解类异戊二烯和萜烯合成酶的低聚物组装
- 批准号:
10328886 - 财政年份:2021
- 资助金额:
$ 152.12万 - 项目类别:














{{item.name}}会员




